Standard

Fused azoloazines with antidiabetic activity. / Rusinov, V. L.; Sapozhnikova, I. M.; Spasov, A. A. et al.
In: Russian Chemical Bulletin, Vol. 71, No. 12, 01.12.2022, p. 2561-2594.

Research output: Contribution to journal › Review article › peer-review

Harvard

Rusinov, VL, Sapozhnikova, IM, Spasov, AA & Chupakhin, ON 2022, 'Fused azoloazines with antidiabetic activity', Russian Chemical Bulletin, vol. 71, no. 12, pp. 2561-2594. https://doi.org/10.1007/s11172-022-3687-8

APA

Rusinov, V. L., Sapozhnikova, I. M., Spasov, A. A., & Chupakhin, O. N. (2022). Fused azoloazines with antidiabetic activity. Russian Chemical Bulletin, 71(12), 2561-2594. https://doi.org/10.1007/s11172-022-3687-8

Vancouver

Rusinov VL, Sapozhnikova IM, Spasov AA, Chupakhin ON. Fused azoloazines with antidiabetic activity. Russian Chemical Bulletin. 2022 Dec 1;71(12):2561-2594. doi: 10.1007/s11172-022-3687-8

Author

Rusinov, V. L. ; Sapozhnikova, I. M. ; Spasov, A. A. et al. / Fused azoloazines with antidiabetic activity. In: Russian Chemical Bulletin. 2022 ; Vol. 71, No. 12. pp. 2561-2594.

BibTeX

@article{067a56a4922f4119909b0416570008c9,
title = "Fused azoloazines with antidiabetic activity",
abstract = "The purpose of this review is to summarize drugs containing an azoloazine moiety and exhibiting antidiabetic activity. The review includes azoloazines active against dipeptidyl peptidase-4, α-glucosidase, and glycogen phosphorylase acting as PPARγ and GPR119 receptor agonists, as well as those inhibiting advanced glycation.",
author = "Rusinov, {V. L.} and Sapozhnikova, {I. M.} and Spasov, {A. A.} and Chupakhin, {O. N.}",
year = "2022",
month = dec,
day = "1",
doi = "10.1007/s11172-022-3687-8",
language = "English",
volume = "71",
pages = "2561--2594",
journal = "Russian Chemical Bulletin",
issn = "1066-5285",
publisher = "Springer",
number = "12",

}

RIS

TY - JOUR

T1 - Fused azoloazines with antidiabetic activity

AU - Rusinov, V. L.

AU - Sapozhnikova, I. M.

AU - Spasov, A. A.

AU - Chupakhin, O. N.

PY - 2022/12/1

Y1 - 2022/12/1

N2 - The purpose of this review is to summarize drugs containing an azoloazine moiety and exhibiting antidiabetic activity. The review includes azoloazines active against dipeptidyl peptidase-4, α-glucosidase, and glycogen phosphorylase acting as PPARγ and GPR119 receptor agonists, as well as those inhibiting advanced glycation.

AB - The purpose of this review is to summarize drugs containing an azoloazine moiety and exhibiting antidiabetic activity. The review includes azoloazines active against dipeptidyl peptidase-4, α-glucosidase, and glycogen phosphorylase acting as PPARγ and GPR119 receptor agonists, as well as those inhibiting advanced glycation.

UR - http://www.scopus.com/inward/record.url?scp=85149065683&partnerID=8YFLogxK

UR - https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=tsmetrics&SrcApp=tsm_test&DestApp=WOS_CPL&DestLinkType=FullRecord&KeyUT=000971659000002

U2 - 10.1007/s11172-022-3687-8

DO - 10.1007/s11172-022-3687-8

M3 - Review article

VL - 71

SP - 2561

EP - 2594

JO - Russian Chemical Bulletin

JF - Russian Chemical Bulletin

SN - 1066-5285

IS - 12

ER -

ID: 35511852